give little insight greed friends pharmaceutical industry consider generally legal drug manufacturers pay generic drug manufacturers manufacture generic copies medications even patents set expire latest new england journal medicine august pharmacies began selling cheaper generic version blockbuster antiplatelet agent plavix clopidogrel good news patients cardiac disease stroke afford buy medication day bristol myers squibb sanofi aventis produce market drug financial disaster plavix world second best selling drug million americans use daily basis sales billion last year accounts percent bristol myers total earnings effort keep generic version market bristol myers sanofi agreed pay canadian manufacturer apotex million release agreement fell deemed unapprovable government authorities bristol myers sanofi would pay break fee least million would take legal action advance stop apotex releasing generic part payoff late apotex would claim interest rate per day chief executive officer ceo barry sherman informed bristol myers executive mail companies pay settlement rejected government reviewers case plavix authorities rejected initial settlement apotex bristol myers sanofi companies reached second settlement end july unravelled wake revelations department justice launching criminal investigation deal week later apotex began flooding market generic clopidogrel within days plavix prescriptions filled generic priced lower brand name product august bristol myers sanofi injunction preventing sales apotex shipped quantities industry analysts expected last case offers rare glimpse high stakes arrangements pharmaceutical companies delay sales generics keep drug prices high watchful eyes federal trade commission ftc department justice though cash payments heart deal shocking reverse payments brand name drug producer generics company illegal unusual case millions promised apotex settlement fell apart generic clopidogrel released sale recent years settlements generally stuck despite federal authorities efforts undo generics kept market article goes describe arrangements relatively common end costing consumers fortune much topic interested readers quick search pharmagossip dozens relevant posts